Viewing StudyNCT00008177



Ignite Creation Date: 2024-05-05 @ 11:19 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00008177
Status: COMPLETED
Last Update Posted: 2019-11-13
First Post: 2001-01-06

Brief Title: Radiolabeled Monoclonal Antibody Therapy Fludarabine Phosphate and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Sponsor: Fred Hutchinson Cancer Center
Organization: Fred Hutchinson Cancer Center

Organization Data

Organization: Fred Hutchinson Cancer Center
Class: OTHER
Study ID: 143200
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Fred Hutchinson Cancer Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH